It is highly expressed in various tumors including breast, colorectal, kidney, prostate, non-small cell lung carcinoma, KRAS-induced lung cancer, and targeting AurB kinases displayed inhibition of cancer progression [58,59,60,61,62]. This evidence concerns the gene KRAS and cancer.